Visão geral da empresa Clinical Data
Biotecnologia e farmacêuticaIndústria
Clinical Data compiles drug research that it hopes will lead to blockbuster clinical trial results. The drug development company focuses on pharmaceutical candidates with an emphasis on treatments for central nervous system and psychiatric disorders, cardiovascular and ocular ailments, and cancers. Following a series of acquisitions, divestitures, and reorganizations, Clinical Data has focused its operations around its PGxHealth division, which engages in drug discovery research and clinical-stage drug development efforts. Its Viibryd antidepressant candidate was approved in 2011. Shortly after the drug's approval, the company was acquired by Forest Laboratories.
